NILHANZA

Serial Number 97771180
731

Registration Progress

Application Filed
Jan 27, 2023
Under Examination
Mar 5, 2024
Approved for Publication
Jan 9, 2024
Published for Opposition
Jan 9, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Sep 05, 2025 36 days

Trademark Image

NILHANZA

Basic Information

Serial Number
97771180
Filing Date
January 27, 2023
Published for Opposition
January 9, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Jun 28, 2025
Application
Pending
Classes
005

Rights Holder

FLEX PHARMA, LLC

16
Address
7101 W. 78TH STREET
MINNEAPOLIS, MN 55439

Ownership History

Nanocopoeia, LLC

Original Applicant
16
New Brighton, MN

Nanocopoeia, LLC

Owner at Publication
16
Minneapolis, MN

FLEX PHARMA, LLC

New Owner After Publication #1
16
MINNEAPOLIS, MN

USPTO Deadlines

Next Deadline
36 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
September 05, 2025
Extension Available
Until March 05, 2025

Application History

38 events
Date Code Type Description Documents
Jun 29, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 28, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 27, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 4, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Mar 4, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 4, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 4, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 4, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 4, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 4, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 4, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 4, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Mar 4, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 4, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 3, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 29, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 29, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 29, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 29, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 5, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 9, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 9, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 20, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 1, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 10, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 9, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 9, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 7, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Aug 7, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
May 9, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 9, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
May 9, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 8, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 8, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 8, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 2, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 15, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 31, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, those for use in human oncology; Tyrosine kinase inhibitors for use in the treatment of cancer; Drugs in the nature of pharmaceutical preparations for use in treating chronic myelogenous leukemia

Classification

International Classes
005